Every Form 4 that UnitedHealth Group Incorporated (UNH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow UNH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full UNH filings page.
UnitedHealth Group director reports quarterly deferred stock grant
A UnitedHealth Group director reported receiving 125 deferred stock units of common stock on January 2, 2026 as regular quarterly compensation for Board service. The filing states these deferred stock units are immediately vested but must be held until the director completes service on the Board. After this grant, the director beneficially owns 125 shares in direct form.
UnitedHealth Group director Michele J. Hooper reported receiving 168 deferred stock units of UnitedHealth Group common stock on 01/02/2026 as regular quarterly compensation for service on the Board. These deferred stock units were granted at a price of $0, are immediately vested, and must be retained until she completes her service as a director. Following this grant, she beneficially owns 41,294 shares of UnitedHealth Group common stock in direct ownership.
UnitedHealth Group director reports quarterly stock compensation. Director Frederick William McNabb III received 316 deferred stock units of UnitedHealth Group common stock on 01/02/2026 at a price of $0, reflecting regular quarterly compensation for board service. Following this grant, he beneficially owns 14,710 shares/units of common stock.
The filing explains that these deferred stock units are immediately vested but must be held until the director completes service on the Board. The report is filed as a Form 4 by a single reporting person and reflects a routine equity-based compensation award for a non-employee director.
UnitedHealth Group Inc. director Charles D. Baker reported a routine equity compensation transaction. On 01/02/2026, he acquired 279 deferred stock units of UnitedHealth Group common stock at a price of $0 per unit. These deferred stock units are granted as regular quarterly compensation for service as a director and are immediately vested, but must be retained until he completes his service on the Board. Following this grant, he beneficially owns 1,806 shares/deferred stock units on a direct basis.
UnitedHealth Group CEO and director Stephen J. Hemsley reported a gift of company stock. On 12/19/2025, he conveyed 55,000 shares of UnitedHealth Group common stock as a gift at a reported price of $0. After this transaction, he beneficially owned 372,947.942 shares directly. He also held 351.9396 shares indirectly through a 401(k) plan and 681,875 shares indirectly through trusts. The filing indicates this was a personal share transfer rather than an open‑market sale.
UnitedHealth Group executive reports routine share accrual from dividends. Timothy J. Noel, Chief Executive Officer of UnitedHealthcare (a unit of UnitedHealth Group Inc.), reported acquiring 44.329 shares of UnitedHealth Group common stock on 12/16/2025. The filing explains this represents dividend equivalents paid on outstanding restricted stock units, which follow the same vesting terms as the underlying awards and are forfeited if those units do not vest.
These shares were acquired at a price of $0, reflecting that they are dividend-related accruals rather than open-market purchases. Following this transaction, Noel directly beneficially owns 9,330.668 shares of UnitedHealth Group common stock.
UnitedHealth Group director reports stock credited from dividend equivalents. On 12/16/2025, a director of UnitedHealth Group Inc. received 43 shares of common stock at a price of $0. These shares represent dividend equivalents paid on vested deferred stock units, and are immediately vested under the same terms as the underlying deferred stock units.
Following this transaction, the director beneficially owns 6,940 shares of UnitedHealth Group common stock in direct form.
UnitedHealth Group executive reports routine share accrual tied to awards
UnitedHealth Group executive Erin L. McSweeney, EVP & Chief People Officer, reported an acquisition of 38.566 shares of UnitedHealth Group common stock on 12/16/2025. The filing explains that this amount represents dividend equivalents paid on outstanding restricted stock units, which follow the same vesting terms as the underlying awards and are forfeited if those units do not vest. After this transaction, McSweeney beneficially owned a total of 11,192.638 shares of common stock in direct form.
UnitedHealth Group director reports receipt of dividend equivalents in stock. A director of UnitedHealth Group Inc. received 11 shares of common stock on 12/16/2025 at a reported price of $0. The filing explains that these shares represent dividend equivalents paid on vested deferred stock units, and that the dividend equivalents are immediately vested and subject to the same terms as the underlying deferred stock units. Following this transaction, the director beneficially owns 1,527 shares of UnitedHealth Group common stock in direct ownership.
UnitedHealth Group CEO and director Stephen J. Hemsley reported a routine insider transaction involving dividend equivalents on his deferred stock units. On 12/16/2025, he acquired 52 shares of common stock at a price of $0, reflecting dividend equivalents that are immediately vested and subject to the same terms as the underlying deferred stock units.
Following this transaction, Hemsley beneficially owns 427,947.942 shares of UnitedHealth Group common stock directly. He also reports indirect ownership of 351.9396 shares through a 401(k) and 681,875 shares through trusts. The filing reflects an incremental increase tied to existing equity compensation rather than an open-market purchase.
UnitedHealth Group director reports small stock accrual from dividends
A UnitedHealth Group Inc. director, Frederick William McNabb III, reported receiving 53 shares of UnitedHealth Group common stock on 12/16/2025. The filing states these shares represent dividend equivalents paid on vested deferred stock units, which are immediately vested and subject to the same terms as the underlying deferred stock units. The transaction was recorded at a price of $0 per share, reflecting that no cash was paid by the director for these shares.
Following this transaction, the director beneficially owns 14,394 shares of UnitedHealth Group common stock in direct ownership. The form was filed as a single-reporting-person Form 4 and signed by an attorney-in-fact on behalf of the director.
UnitedHealth Group director John H. Noseworthy, M.D. reported a small increase in his holdings of UnitedHealth Group common stock. On 12/16/2025, he acquired 43 shares at a price of $0, described as dividend equivalents paid on vested deferred stock units. These dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units. Following this transaction, he beneficially owns 6,736 shares of UnitedHealth Group common stock in direct ownership.
UnitedHealth Group director Kristen L. Gil reported a small change in her holdings of UnitedHealth Group common stock. On 12/16/2025, she acquired 7 shares of common stock at a price of $0, recorded as dividend equivalents paid on vested deferred stock units. After this transaction, she beneficially owned 1,907 shares directly and 3,800 shares indirectly through a trust. The dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units.
UnitedHealth Group executive Christopher R. Zaetta, EVP & Chief Legal Officer, reported acquiring additional UnitedHealth Group common stock through dividend equivalents on restricted stock units. On 12/16/2025, he acquired 44.528 shares at a price of $0, reflecting reinvested dividends rather than an open-market purchase. These dividend equivalents are subject to the same vesting conditions as the underlying restricted stock units and are forfeited if those units do not vest. Following this transaction, Zaetta beneficially owns 10,327.804 shares of UnitedHealth Group common stock in direct ownership.
UnitedHealth Group insider Patrick H. Conway, Chief Executive Officer of Optum, reported an increase in his holdings of company common stock through dividend equivalents on restricted stock units. On 12/16/2025, he acquired 67.721 shares at a price of $0, reflecting stock dividends credited on his outstanding restricted stock units. After this transaction, he beneficially owned 10,603.915 shares of UnitedHealth Group common stock in direct ownership. The filing notes that these dividend equivalents are subject to the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest.
UnitedHealth Group reported an insider equity update for its Chief Financial Officer. On 12/16/2025, the CFO acquired 70.042 shares of UnitedHealth Group common stock at a price of $0. These shares represent dividend equivalents credited on outstanding restricted stock units, meaning additional shares were granted in lieu of cash dividends on those units.
Following this transaction, the CFO beneficially owns 10,661.941 shares of UnitedHealth Group common stock in direct ownership. The dividend-equivalent shares are subject to the same vesting and forfeiture conditions as the underlying restricted stock units.
UnitedHealth Group Inc. director Timothy P. Flynn reported a small increase in his holdings of the company’s common stock through an insider transaction dated 12/16/2025. The filing shows an acquisition of 65 shares of common stock at a stated price of $0, described as dividend equivalents paid on vested deferred stock units that are immediately vested and follow the same terms as the underlying units.
After this transaction, Flynn beneficially owned 9,875 shares of UnitedHealth Group common stock directly and 6,033 shares indirectly through a trust. The form is filed for one reporting person and is signed by an attorney-in-fact on Flynn’s behalf.
UnitedHealth Group director reports additional stock via dividend equivalents. Director Michele J. Hooper reported acquiring 249 shares of UnitedHealth Group common stock on 12/16/2025 at a price of $0 per share. These shares represent dividend equivalents paid on vested deferred stock units and are immediately vested, carrying the same terms as the underlying deferred stock units. Following this transaction, she beneficially owns 41,126 shares of UnitedHealth Group common stock in direct ownership.
UnitedHealth Group director reports small stock-related award. A UnitedHealth Group Inc. director reported receiving 13 shares of common stock on 12/16/2025 as dividend equivalents on vested deferred stock units, at a stated price of $0. These dividend equivalents vest immediately and follow the same terms as the underlying deferred stock units. After this transaction, the director holds 3,034 UnitedHealth Group shares directly, and additional indirect holdings of 2,146 shares through a revocable trust, 45 shares through one trust, and 55 shares through another trust.
UnitedHealth Group’s Chief Accounting Officer, Thomas E. Roos, reported an automatic increase in his holdings of company common stock. On 12/16/2025, he acquired 23.408 shares of common stock at a price of $0, coded as an acquisition, bringing his total directly held beneficial ownership to 29,642.927 shares.
The filing explains that these additional shares represent dividend equivalents credited on outstanding restricted stock units. These dividend equivalents follow the same vesting conditions as the underlying restricted stock units and will be forfeited if those units do not vest, meaning the added shares are still subject to performance or service-based requirements.